Mexico Recombinant Proteins Market Size & Outlook
Mexico recombinant proteins market, 2018-2030 (US$M)
Related Markets
Mexico recombinant proteins market highlights
- The Mexico recombinant proteins market generated a revenue of USD 50.9 million in 2022 and is expected to reach USD 110.6 million by 2030.
- The Mexico market is expected to grow at a CAGR of 10.2% from 2023 to 2030.
- In terms of segment, product was the largest revenue generating product & services in 2022.
- Services is the most lucrative product & services segment registering the fastest growth during the forecast period.
Recombinant proteins market data book summary
| Market revenue in 2022 | USD 50.9 million |
| Market revenue in 2030 | USD 110.6 million |
| Growth rate | 10.2% (CAGR from 2022 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Product |
| Key market players worldwide | Abcam PLC, Sino Biological, Bio-Techne Corp, Genscript Biotech Corp Class H, Bio-Rad Laboratories Inc, Merck KGaA, Thermo Fisher Scientific Inc, Proteintech Group, Enzo Biochem Inc, Abnova, RayBiotech, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, Mexico accounted for 2.5% of the global recombinant proteins market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil recombinant proteins market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 111.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Recombinant Proteins Market Scope
Recombinant Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico recombinant proteins market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to recombinant proteins market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 68.76% in 2024. Horizon Databook has segmented the Mexico recombinant proteins market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
- Mexico Recombinant Proteins Product Outlook (Revenue, USD Million, 2018-2030)
- Cytokines & Growth Factors
- Interferons (IFNs)
- Interleukins (ILs)
- Others
- Antibodies
- Immune checkpoint proteins
- Virus Antigens
- Enzymes
- Kinases
- Metabolic enzymes
- Others
- Recombinant Regulatory Protein
- Hormones
- Others
- Cytokines & Growth Factors
- Mexico Recombinant Proteins Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Discovery & Development
- Research
- Others
- Therapeutics
- Biologics
- Vaccines
- Cell & Gene Therapies
- Others
- Mexico Recombinant Proteins Host Cells Outlook (Revenue, USD Million, 2018-2030)
- Mammalian Systems
- Insect Cells
- Yeast & Fungi
- Bacterial Cells
- Others
- Mexico Recombinant Proteins End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Diagnostic Laboratories
- Others
Reasons to subscribe to Mexico recombinant proteins market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico recombinant proteins market databook
-
Our clientele includes a mix of recombinant proteins market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico recombinant proteins market , including forecasts for subscribers. This country databook contains high-level insights into Mexico recombinant proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico recombinant proteins market
Mexico Recombinant Proteins Market Outlook Share, 2024 & 2030 (US$M)
Mexico recombinant proteins market
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
